Drug Shortage Report for FLUMAZENIL INJECTION
Report ID | 151320 |
Drug Identification Number | 02249561 |
Brand name | FLUMAZENIL INJECTION |
Common or Proper name | FLUMAZENIL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | FLUMAZENIL |
Strength(s) | 0.1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5ML 10LIVI |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-01-26 |
Estimated end date | 2022-02-03 |
Actual end date | 2022-01-26 |
Shortage status | Resolved |
Updated date | 2022-01-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-12-16 | English | Compare |
v2 | 2021-12-16 | French | Compare |
v3 | 2021-12-22 | English | Compare |
v4 | 2022-01-26 | English | Compare |
v5 | 2022-01-26 | French | Compare |
v6 | 2022-01-26 | English | Compare |
v7 | 2022-01-26 | French | Compare |
v8 | 2022-01-27 | English | Compare |
Showing 1 to 8 of 8